Xtant Medical Holdings, Inc.
XTNT · AMEX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $102,951 | $67,475 | $61,567 |
| - Cash | $10,400 | $6,923 | $5,032 | $6,199 |
| + Debt | $2,971 | $14,796 | $34,295 | $35,143 |
| Enterprise Value | – | $110,824 | $96,738 | $90,511 |
| Revenue | $33,255 | $35,411 | $32,904 | $31,513 |
| % Growth | -6.1% | 7.6% | 4.4% | – |
| Gross Profit | $21,992 | $24,284 | $20,243 | $16,024 |
| % Margin | 66.1% | 68.6% | 61.5% | 50.8% |
| EBITDA | $3,630 | $5,978 | $2,152 | -$862 |
| % Margin | 10.9% | 16.9% | 6.5% | -2.7% |
| Net Income | $1,308 | $3,550 | $58 | -$3,165 |
| % Margin | 3.9% | 10% | 0.2% | -10% |
| EPS Diluted | 0.009 | 0.024 | 0 | -0.023 |
| % Growth | -63.2% | 5,875% | 101.8% | – |
| Operating Cash Flow | $4,612 | $1,276 | $1,278 | $665 |
| Capital Expenditures | -$430 | -$366 | -$1,191 | -$672 |
| Free Cash Flow | $4,182 | $910 | $87 | -$7 |